Phase I/II Study of Neoadjuvant Chemoradiotherapy Consisting of S-1 and Cisplatin for Patients with Clinically Resectable Type 4 or Large Type 3 Gastric Cancer (OGSG1205).
Saved in:
| Title: | Phase I/II Study of Neoadjuvant Chemoradiotherapy Consisting of S-1 and Cisplatin for Patients with Clinically Resectable Type 4 or Large Type 3 Gastric Cancer (OGSG1205). |
|---|---|
| Authors: | Shinkai M; Department of Surgery, Faculty of Medicine, Kindai University, Osaka-Sayama, Osaka, Japan., Imano M; Department of Surgery, Faculty of Medicine, Kindai University, Osaka-Sayama, Osaka, Japan. imano@med.kindai.ac.jp., Yokokawa M; Department of Radiation Oncology, Faculty of Medicine, Kindai University, Osaka-Sayama, Osaka, Japan., Tanaka R; Department of General and Gastroenterological Surgery, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan., Matsuyama J; Department of Gastroenterological Surgery, Higashiosaka City Medical Center, Higashiosaka, Osaka, Japan., Shimokawa T; Clinical Study Support Center, Wakayama Medical University, Wakayama, Japan., Kawakami H; Department of Medical Oncology, Faculty of Medicine, Kindai University, Osaka-Sayama, Osaka, Japan., Satoh T; Center for Cancer Genomics and Precision Medicine, Osaka University Hospital, Suita, Osaka, Japan., Yasuda T; Department of Surgery, Faculty of Medicine, Kindai University, Osaka-Sayama, Osaka, Japan., Furukawa H; Department of Surgery, Faculty of Medicine, Kindai University, Osaka-Sayama, Osaka, Japan. |
| Source: | Annals of surgical oncology [Ann Surg Oncol] 2025 Apr; Vol. 32 (4), pp. 2651-2661. Date of Electronic Publication: 2025 Jan 15. |
| Publication Type: | Journal Article; Clinical Trial, Phase I; Clinical Trial, Phase II |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
